Skip to content

Prognostic Values of Coronary Microvascular Dysfunction in Patients With Dilated Cardiomyopathy

Prognostic Values of Coronary Microvascular Dysfunction in Patients With Dilated Cardiomyopathy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07293338
Enrollment
330
Registered
2025-12-19
Start date
2026-01-06
Completion date
2027-12-01
Last updated
2025-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dilated Cardiomyopathy (DCM)

Brief summary

The goal of this observational study is to learn about the long-term prognostic of coronary microvascular dysfuction in Patients with Dilated Cardiomyopathy. The main question it aims to answer is: Does the coronary microvascular dysfunction impact the outcomes in Patients with Dilated Cardiomyopathy.

Interventions

PROCEDUREcoronary angiography

Patients should undergo coronary angiography to confirm the absence of significant coronary stenosis. Angio-IMR was calculated based on the angiography.

Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Dilated cardiomyopathy comfirmed by echocardiography: LVDd \> 55 mm in men or \> 50 mm in women. * Clinically evident congestive heart failure: Compatible symptoms and signs, and BNP ≥ 35 pg/mL or NT-proBNP ≥ 125 pg/mL, and LV systolic dysfunction defined by LVEF \< 45 %. * Coronary angiography showing stenosis ≤ 50 % in all major epicardial vessels.

Exclusion criteria

* Patients with coronary artery disease, hypertensive heart disease, rheumatic valvular heart disease, myocarditis, and other secondary cardiomyopathies. * poor angiographic image quality

Design outcomes

Primary

MeasureTime frameDescription
Major adverse cardiac eventsAt 5-year follow-upA composite of cardiac death, hospitalization for heart failure, heart transplantation, and device implantation

Countries

China

Contacts

Primary ContactJun Jiang, MD
21918219@zju.edu.cn+86 15657125311

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026